Evidence map›Paper›PMID 40786915›Full record

ArticleOrthopaedic journal of sports medicine2025

Development of Explainable Machine Learning Models to Predict Outcomes After Platelet-Rich Plasma Injections for Knee Osteoarthritis.

Felix Conrad Oettl, Antonio Madrazo Ibarra, Mark A Fontana, Ophelie Loblack, Mert Marcel Dagli, Miguel Otero, Jessica Andres Bergos, Brian C Halpern, Scott A Rodeo

Abstract read
In one paragraph

Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Felix Conrad OettlHospital for Special Surgery, New York, New York, USA.ORCID https://orcid.org/0000-0001-9721-685X
Antonio Madrazo IbarraHospital for Special Surgery, New York, New York, USA.
Mark A FontanaHospital for Special Surgery, New York, New York, USA.
Ophelie LoblackHospital for Special Surgery, New York, New York, USA.
Mert Marcel DagliDepartment of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Miguel OteroHospital for Special Surgery, New York, New York, USA.
Jessica Andres BergosHospital for Special Surgery, New York, New York, USA.
Brian C HalpernHospital for Special Surgery, New York, New York, USA.
Scott A RodeoHospital for Special Surgery, New York, New York, USA.ORCID https://orcid.org/0000-0002-0745-9880

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Platelet-rich plasma (PRP) has been increasingly used to treat knee osteoarthritis, but its efficacy remains unclear due to the variability of outcomes. Machine learning (ML) can improve the ability to predict responses to PRP treatment by identifying specific baseline characteristics of patients who may have greater clinical improvements. Purpose: To develop and evaluate an ML model predicting clinical outcomes after PRP injection for knee osteoarthritis. Study design: Cohort study (prognosis); Level of evidence, 2. Methods: This retrospective study utilized patient demographics and patient-reported outcome measures (PROMs) from 191 patients who received PRP injections for knee osteoarthritis. Patients were randomly split into a training set (80%) and a testing set (20%). The primary outcome was predicting the achievement of the minimal clinically important difference at 6 months after treatment, defined as a ≥10-point increase in the Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR) and a ≥20% decrease in the numeric pain rating scale for knee pain score. Ten preinjection variables, including demographics and baseline PROMs, were evaluated. Multiple ML algorithms were developed and evaluated on sensitivity, accuracy, precision, area under the receiver operating characteristic curve (AUC)-ROC, and Results: The Explainable Boosting Machine (EBM) algorithm was determined to be the best algorithm due to its greater explainability (AUC-ROC, 0.81 [95% CI, 0.65-0.94]; Conclusion: ML models effectively predicted a clinically meaningful improvement at 6 months after PRP injection for knee osteoarthritis. The EBM was the algorithm with the best performance, with the PROMIS Mental and Physical scores and the KOOS Jr score being the most influential predictors. Additional independent studies are needed to externally validate this model.

Indexed as

artificial intelligencekneemachine learningminimal clinically important differenceosteoarthritisplatelet-rich plasma

Identifiers

PMID40786915
PMCPMC12332376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.